CTLA-4 antibody dosage escalation regimens

Details for Australian Patent Application No. 2006321593 (hide)

Owner Medarex, Inc.

Inventors Nichol, Geoffrey M.; Lowy, Israel

Agent Davies Collison Cave

Pub. Number AU-B-2006321593

PCT Pub. Number WO2007/067959

Priority 60/748,688 07.12.05 US

Filing date 7 December 2006

Wipo publication date 14 June 2007

Acceptance publication date 4 October 2012

International Classifications

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/067959 Priority application(s): WO2007/067959

4 October 2012 Application Accepted

  Published as AU-B-2006321593

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006321602-Effects of inhibitors of FGFR3 on gene transcription

2006321574-Assessment of electrode coupling for tissue ablation